ArcticZymes Technologies ASA (STU:B4V)
€ 1.114 -0.002 (-0.18%) Market Cap: 56.93 Mil Enterprise Value: 37.30 Mil PE Ratio: 167.50 PB Ratio: 2.15 GF Score: 62/100

Q1 2019 Biotec Pharmacon ASA Earnings Call Transcript

Apr 30, 2019 / 06:30AM GMT
Release Date Price: €0.42
Christian JÃ;rgensen
Biotec Pharmacon ASA - CEO

¸ -

Yes, good morning and welcome to the Q1 presentation for Biotec Pharmacon. I'd like to welcome the people here in Oslo who are present. I'd also like to welcome people on the web, and I'm sure that there's a lot of colleagues from Tromsø who's also watching this as I've said many times, one of the biggest shareholder groups in the company are the employees of the company.

So shareholders for us is a very real thing. It's something we discuss every day at the lunch table, how the share price is developing because a large number of the employees of the company are shareholders. So a warm welcome to, as I said, everybody in Oslo and people on the web.

The agenda is what we usually go through, nothing has changed there. This is just a thing that -- just to remind people of what we are, what I think is important that we come from Tromsø University and we are based in Tromsø, and we have a very good relationship with the University that we benefit from today. So not even -- not only did actually the company originate from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot